AAAAAA

   
Results: 1-13 |
Results: 13
Human inflammatory cells within the tumor microenvironment of lung tumor xenografts mediate tumor growth suppression in situ that depends on and is augmented by interleukin-12
Authors: Sugiyama, Y Kato, M Chen, FA Williams, SS Kawaguchi, Y Miya, K Jong, YS Mathiowitz, E Egilmez, NK Bankert, RB
Citation: Y. Sugiyama et al., Human inflammatory cells within the tumor microenvironment of lung tumor xenografts mediate tumor growth suppression in situ that depends on and is augmented by interleukin-12, J IMMUNOTH, 24(1), 2001, pp. 37-45
Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies
Authors: Bankert, RB Egilmez, NK Hess, SD
Citation: Rb. Bankert et al., Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies, TRENDS IMMU, 22(7), 2001, pp. 386-393
Antitumor efficacy of a human interleukin-12 expression plasmid demonstrated in a human peripheral blood leukocyte/human lung tumor xenograft SCID mouse model
Authors: Hess, SD Egilmez, NK Shiroko, J Bankert, RB
Citation: Sd. Hess et al., Antitumor efficacy of a human interleukin-12 expression plasmid demonstrated in a human peripheral blood leukocyte/human lung tumor xenograft SCID mouse model, CANC GENE T, 8(5), 2001, pp. 371-377
Human dendritic cells pulsed with autologous Epstein-Barr virus transformed B-cell lymphoblastoid cell (BCL) lysate elicit a BCL specific MHC-Class II restricted T-cell response
Authors: Sugano, M Conway, TF Kelleher, RJ Sugiyama, Y Chen, FA Bankert, RB Bernstein, SH
Citation: M. Sugano et al., Human dendritic cells pulsed with autologous Epstein-Barr virus transformed B-cell lymphoblastoid cell (BCL) lysate elicit a BCL specific MHC-Class II restricted T-cell response, J EXP CL C, 20(2), 2001, pp. 175-182
Neoadjuvant therapy with interleukin-12-loaded polylactic acid microspheres reduces local recurrence and distant metastases
Authors: Sabel, MS Hill, H Jong, YS Mathiowitz, E Bankert, RB Egilmez, NK
Citation: Ms. Sabel et al., Neoadjuvant therapy with interleukin-12-loaded polylactic acid microspheres reduces local recurrence and distant metastases, SURGERY, 130(3), 2001, pp. 470-478
CD40-CD40 ligand (CD154) engagement is required but not sufficient for modulating MHC class I, ICAM-1 and Fas expression and proliferation of human non-small cell lung tumors
Authors: Yamada, M Shiroko, T Kawaguchi, Y Sugiyama, Y Egilmez, NK Chen, FA Bankert, RB
Citation: M. Yamada et al., CD40-CD40 ligand (CD154) engagement is required but not sufficient for modulating MHC class I, ICAM-1 and Fas expression and proliferation of human non-small cell lung tumors, INT J CANC, 92(4), 2001, pp. 589-599
Monoclonal antibodies directed against the T-cell activation molecule CD137 (interleukin-A or 4-1BB) block human lymphocyte-mediated suppression of tumor xenografts in severe combined immunodeficient mice
Authors: Sabel, MS Conway, TF Chen, FA Bankert, RB
Citation: Ms. Sabel et al., Monoclonal antibodies directed against the T-cell activation molecule CD137 (interleukin-A or 4-1BB) block human lymphocyte-mediated suppression of tumor xenografts in severe combined immunodeficient mice, J IMMUNOTH, 23(3), 2000, pp. 362-368
Cytokines delivered by biodegradable microspheres promote effective suppression of human tumors by human peripheral blood lymphocytes in the SCID-Winn model
Authors: Egilmez, NK Jong, YS Hess, SD Jacob, JS Mathiowitz, E Bankert, RB
Citation: Nk. Egilmez et al., Cytokines delivered by biodegradable microspheres promote effective suppression of human tumors by human peripheral blood lymphocytes in the SCID-Winn model, J IMMUNOTH, 23(2), 2000, pp. 190-195
Interleukin-12 delivered by biodegradable microspheres promotes the antitumor activity of human peripheral blood lymphocytes in a human head and necktumor xenograft/SCID mouse model
Authors: Kuriakose, MA Chen, FA Egilmez, NK Jong, YS Mathiowitz, E DeLacure, MD Hicks, WL Loree, TL Bankert, RB
Citation: Ma. Kuriakose et al., Interleukin-12 delivered by biodegradable microspheres promotes the antitumor activity of human peripheral blood lymphocytes in a human head and necktumor xenograft/SCID mouse model, HEAD NECK, 22(1), 2000, pp. 57-63
CD40 expression on human lung cancer correlates with metastatic spread
Authors: Sabel, MS Yamada, M Kawaguchi, Y Chen, FA Takita, H Bankert, RB
Citation: Ms. Sabel et al., CD40 expression on human lung cancer correlates with metastatic spread, CANCER IMMU, 49(2), 2000, pp. 101-108
Growth of human tumor xenografts in SCID mice quantified using an immunoassay for tumor marker protein in serum
Authors: Conway, TF Sabel, MS Sugano, M Frelinger, JG Egilmez, NK Chen, FA Bankert, RB
Citation: Tf. Conway et al., Growth of human tumor xenografts in SCID mice quantified using an immunoassay for tumor marker protein in serum, J IMMUNOL M, 233(1-2), 2000, pp. 57-65
Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice
Authors: Sugano, M Egilmez, NK Yokota, SJ Chen, FA Harding, J Huang, SK Bankert, RB
Citation: M. Sugano et al., Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice, CANCER RES, 60(24), 2000, pp. 6942-6949
In situ tumor vaccination with interleukin-12-encapsulated biodegradable microspheres: Induction of tumor regression and potent antitumor immunity
Authors: Egilmez, NK Jong, YS Sabel, MS Jacob, JS Mathiowitz, E Bankert, RB
Citation: Nk. Egilmez et al., In situ tumor vaccination with interleukin-12-encapsulated biodegradable microspheres: Induction of tumor regression and potent antitumor immunity, CANCER RES, 60(14), 2000, pp. 3832-3837
Risultati: 1-13 |